Effects of Telemonitoring in Quality of Life Amongst Cancer Patients
Effects in Quality of Life of a Telemonitoring Platform Amongst Patients With Cancer: A Randomized Trial
Universidad Nacional Andres Bello
80 participants
Apr 1, 2024
INTERVENTIONAL
Conditions
Summary
This interventional study aims to explore the potential of a smartphone app, Contigo, in enhancing the quality of life for patients with various cancers compared to standard care. The investigators will asses effects on quality of life, depressive symptoms, and appointment adherence.
Eligibility
Inclusion Criteria5
- Adult patients (>18 years old).
- Recent histologically confirmed diagnosis (within the last 3 months) of bronchogenic, breast, gallbladder, gastric, colorectal, or prostate cancer in any of its forms.
- Awaiting initiation of curative intent treatment for the disease using any modality (radiation therapy, chemotherapy, immunotherapy, etc.) at the UC-Christus Cancer Center.
- Possession of a smartphone, regardless of its native operating system (iOS® or Android®).
- Willingness to sign an informed consent form to participate in the study.
Exclusion Criteria5
- Any form of sensory impairment preventing app usage.
- Cognitive impairment.
- Psychiatric pathology hindering app usage.
- Unwillingness to participate in the study.
- Concurrent participation in another clinical trial addressing healthcare technologies.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Contigo, a smartphone app, focuses on two main goals: monitoring cancer patients for early signs of drug toxicity and offering educational content to empower them in managing clinical challenges linked to their diagnosis and treatment. Monitoring involves patients inputting experiences via oncology-related questionnaires, with weekly checks for chemotherapy toxicity using a validated questionnaire (PRO-CTCAE). Severe cases trigger alerts, while milder ones receive educational guidance. Data collected is shared with healthcare providers. Educational content, backed by scientific evidence and expert collaboration, covers cancer-specific topics and healthcare processes to enhance patients' self-awareness and self-care practices.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06086990